Diabetes drugmaker Structure Therapeutics stock soars 72% in market debut

[ad_1] ismagilov/iStock via Getty Images Structure Therapeutics (GPCR) stock rallied 72% in afternoon trading Friday after the diabetes drug developer raised $161M through an upsized US initial public offering. American Depositary Shares of the company, which has operations in both the US and China, opened at $25 after being priced at $15 apiece. The stock … Read more